Incremental Value of Cystatin C Over Conventional Renal Metrics for Predicting Clinical Response and Outcomes in Cardiac Resynchronization Therapy: The BIOCRT Study

BACKGROUND: Despite the benefit of CRT in select patients with heart failure (HF), there remains significant need for predicting those at risk for adverse outcomes for this effective but costly therapy. CysC, an emerging marker of renal function, is predictive of worsening symptoms and mortality in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cardiol
Autors principals: Chatterjee, Neal A., Singh, Jagmeet P., Szymonifka, Jackie, Deaño, Roderick C., Thai, Wai-ee, Wai, Bryan, Min, James K., Januzzi, James L., Truong, Quynh A.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718799/
https://ncbi.nlm.nih.gov/pubmed/26710332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2015.12.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars